Clopidogrel results in favourable changes in nitric oxide metabolism in patients undergoing percutaneous coronary intervention

Thromb Haemost. 2014 Feb;111(2):373-4. doi: 10.1160/TH13-05-0394. Epub 2013 Oct 24.
No abstract available

Publication types

  • Letter

MeSH terms

  • Biomarkers / blood
  • Clopidogrel
  • Coronary Artery Disease / blood
  • Coronary Artery Disease / diagnosis
  • Coronary Artery Disease / physiopathology
  • Coronary Artery Disease / therapy*
  • Cyclic GMP / blood
  • Humans
  • Nitrates / blood
  • Nitric Oxide / blood*
  • Nitrites / blood
  • Percutaneous Coronary Intervention* / adverse effects
  • Percutaneous Coronary Intervention* / instrumentation
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Prospective Studies
  • Stents
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / therapeutic use
  • Time Factors
  • Treatment Outcome
  • Vasodilation / drug effects
  • Wales

Substances

  • Biomarkers
  • Nitrates
  • Nitrites
  • Platelet Aggregation Inhibitors
  • Nitric Oxide
  • Clopidogrel
  • Cyclic GMP
  • Ticlopidine